论文部分内容阅读
目的分析顺尔宁辅助治疗婴幼儿喘息性疾病的疗效。方法选择80例喘息性支气管炎患儿,随机分为治疗组和对照组各40例,对照组给予常规治疗方法,治疗组在常规治疗的基础上增加口服顺尔宁。结果治疗组有效率明显优于对照组(P<0.05),咳喘消失时间及肺部啰音消失时间较对照组明显缩短,差异有统计学意义(P<0.05)。结论顺尔宁口服作为婴幼儿喘息性支气管炎辅助治疗方法不仅安全,而且疗效确切,可缩短患儿住院时间,改善预后效果。
Objective To analyze the effect of Shun-ning’s adjuvant treatment of infantile asthmatic disease. Methods Eighty children with asthmatic bronchitis were randomly divided into treatment group (n = 40) and control group (n = 40). The control group was given routine treatment. The treatment group received oral salbutamol supplementation on the basis of routine treatment. Results The effective rate of the treatment group was significantly better than that of the control group (P <0.05). The disappearance time of asthma and pulmonary rales disappeared significantly compared with that of the control group. The difference was statistically significant (P <0.05). Conclusion As an adjuvant therapy for asthmatic bronchitis in infants and young children, oral salbutamol is not only safe but also effective in reducing hospitalization time and improving prognosis.